147 related articles for article (PubMed ID: 30520434)
1. Diffusion Kurtosis Imaging Reflects Glial Fibrillary Acidic Protein (GFAP), Topo IIα, and O⁶-Methylguanine-DNA Methyltransferase (MGMT) Expression in Astrocytomas.
Wang XC; Lei Y; Wang L; Tan Y; Qin JB; Ma GL; Zhang H
Med Sci Monit; 2018 Dec; 24():8822-8830. PubMed ID: 30520434
[TBL] [Abstract][Full Text] [Related]
2. Diffusion Kurtosis Imaging Reflects GFAP, TopoIIα, and MGMT Expression in Astrocytomas.
Wang XC; Tan Y; Zhang H; Qin JB; Lei Y; Hao XY
Neurol India; 2021; 69(1):119-125. PubMed ID: 33642282
[TBL] [Abstract][Full Text] [Related]
3. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
[TBL] [Abstract][Full Text] [Related]
4. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
5. Combination value of diffusion-weighted imaging and dynamic susceptibility contrast-enhanced MRI in astrocytoma grading and correlation with GFAP, Topoisomerase IIα and MGMT.
Qin JB; Zhang H; Wang XC; Tan Y; Wu XF
Oncol Lett; 2019 Sep; 18(3):2763-2770. PubMed ID: 31452754
[TBL] [Abstract][Full Text] [Related]
6. Comparing the value of DKI and DTI in detecting isocitrate dehydrogenase genotype of astrocytomas.
Tan Y; Zhang H; Wang X; Qin J; Wang L; Yang G; Yan H
Clin Radiol; 2019 Apr; 74(4):314-320. PubMed ID: 30771996
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of high-grade-astrocytomas from solitary-brain-metastases: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
Tan Y; Wang XC; Zhang H; Wang J; Qin JB; Wu XF; Zhang L; Wang L
Eur J Radiol; 2015 Dec; 84(12):2618-24. PubMed ID: 26482747
[TBL] [Abstract][Full Text] [Related]
8. Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.
Huang L; Jiang T; Yuan F; Li GL; Cui Y; Liu EZ; Wang ZC
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):367-379. PubMed ID: 19019173
[TBL] [Abstract][Full Text] [Related]
9. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging.
Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J
World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064
[TBL] [Abstract][Full Text] [Related]
10. Lipidized glioblastoma: pathological and molecular characteristics.
Singh AD; Iftinca M; Easaw JC
Neuropathology; 2013 Feb; 33(1):87-92. PubMed ID: 22640269
[TBL] [Abstract][Full Text] [Related]
11. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
Han Y; Yan LF; Wang XB; Sun YZ; Zhang X; Liu ZC; Nan HY; Hu YC; Yang Y; Zhang J; Yu Y; Sun Q; Tian Q; Hu B; Xiao G; Wang W; Cui GB
BMC Cancer; 2018 Feb; 18(1):215. PubMed ID: 29467012
[TBL] [Abstract][Full Text] [Related]
12. Predictive markers for MGMT promoter methylation in glioblastomas.
Kanazawa T; Minami Y; Jinzaki M; Toda M; Yoshida K; Sasaki H
Neurosurg Rev; 2019 Dec; 42(4):867-876. PubMed ID: 30673883
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional expression of glioma chemotherapy drugs associated marker molecules in gliomas and normal brain tissues.
Zhao Y; Xue Y; Zhang Q; Wang K; Yin J; Lou M
Cancer Biomark; 2013; 13(1):59-66. PubMed ID: 23736022
[TBL] [Abstract][Full Text] [Related]
14. [IDH1 mutation and MGMT expression in astrocytoma and the relationship with prognosis after radiotherapy].
Jiang M; Dong X; Li J; Li J; Qi J
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):668-72. PubMed ID: 25567592
[TBL] [Abstract][Full Text] [Related]
15. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
16. MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma.
Christmann M; Nagel G; Horn S; Krahn U; Wiewrodt D; Sommer C; Kaina B
Int J Cancer; 2010 Nov; 127(9):2106-18. PubMed ID: 20131314
[TBL] [Abstract][Full Text] [Related]
17. Does the expression of glial fibrillary acid protein (GFAP) stain in glioblastoma tissue have a prognostic impact on survival?
Ahmadipour Y; Gembruch O; Pierscianek D; Sure U; Jabbarli R
Neurochirurgie; 2020 Jun; 66(3):150-154. PubMed ID: 32278699
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the values of MRI diffusion kurtosis imaging and diffusion tensor imaging in cerebral astrocytoma grading and their association with aquaporin-4.
Tan Y; Zhang H; Zhao RF; Wang XC; Qin JB; Wu XF
Neurol India; 2016; 64(2):265-72. PubMed ID: 26954804
[TBL] [Abstract][Full Text] [Related]
19. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
[TBL] [Abstract][Full Text] [Related]
20. Molecular Characteristics of Thalamic Gliomas in Adults.
Wang T; Niu X; Gao T; Zheng L; Qiu Y; Mao Q
J Mol Neurosci; 2021 Aug; 71(8):1598-1604. PubMed ID: 33523385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]